Holistic Expression of MiR-17-92 Cluster in Obesity, Kidney Diseases, Cardiovascular Diseases, and Diabetes
Overview
Affiliations
miR-17-92 cluster encodes six micro RNAs (miRNAs) and plays a crucial role in the regulation of various cellular processes. Aberrant expression of this cluster may result in the onset of several diseases. Initially, the role of miR-17-92 cluster in tumorigenesis was discovered but recent research has also uncovered its role in other diseases. Members of the cluster may serve as potential biomarkers in the prognosis, diagnosis, and treatment of several diseases and their complications. In this article, we have reviewed the recent research carried out on the expression pattern of miR-17-92 cluster in non-communicable diseases i.e., obesity, cardiovascular diseases (CVD), kidney diseases (KD) and diabetes mellitus (DM). We examined miR-17-92 role in pathological processes and their potential importance as biomarkers. Each member of the cluster miR-17-92 was upregulated in obesity. miR-18a, miR-19b-3p, miR20a, and miR92a were significantly upregulated in CVD. An equal fraction of the cluster was dysregulated (upregulated and downregulated) in diabetes; however, miR-17-92 was downregulated in most studies on CKD.
Exosomal miR-17-92 Cluster from BMSCs Alleviates Apoptosis and Inflammation in Spinal Cord Injury.
Wang W, Yao F, Xing H, Yang F, Yan L Biochem Genet. 2024; .
PMID: 38961001 DOI: 10.1007/s10528-024-10876-5.
Wu X, Wu X, Wang Z, Tian X, Zhang C, Cao G Drug Deliv Transl Res. 2024; 15(3):925-938.
PMID: 38918324 DOI: 10.1007/s13346-024-01645-3.